Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hormone replacement therapy should start early

14.07.2004


Don’t categorically reject hormone replacement therapy (HRT) just yet: When women begin HRT before age 60, their risk of death is 39 percent less than women not on hormones, according to a new survey.



The findings are based on a Cornell University-Stanford University meta-analysis (a study of other previously published studies), which pooled the results of 30 clinical trials of HRT with almost 27,000 women.

"The results of our analysis indicate that the benefits of HRT outweigh the risks in women who have recently entered menopause," says Edwin E. Salpeter, who did the statistical analyses for the study. Salpeter is a professor of physics emeritus at Cornell and the 1997 Crafoord Prize laureate who has turned his interest to medical issues in recent years.


The first author of the study, which is published in the July issue of the Journal of General Internal Medicine (Vol. 19:7, 2004), is his daughter, Shelley R. Salpeter, M.D., a clinical professor of medicine at Stanford University School of Medicine and a physician at Santa Clara Valley Medical Center in San Jose, Calif.

The new findings appear contrary to two large, well-publicized studies, the Heart and Estrogen/Progestin Replacement Study and the Women’s Health Initiative, which found no difference in mortality rates for those taking HRT or a placebo. Women taking HRT, these two studies found, had increases in breast cancer, stroke, heart attacks and pulmonary embolism and decreases in colon cancer, hip fractures and diabetes mellitus. The conclusion from these trials was that the risks of HRT outweighed the benefits in these patients. However, these findings were based on samples of women whose mean age was 65 years at the start of the trial.

However, an earlier survey, the Nurses’ Health Study, says Shelley Salpeter, "was a large prospective study that found that women who started treatment within two years of menopause had a total mortality risk of 0.63 that of nonusers. Our findings are consistent with this result and suggest that HRT may help prevent and perhaps even halt the progression of cardiovascular disease when started in women in early postmenopause."

She notes, however, that the accumulated evidence suggests that once heart disease has already developed, HRT has no effect in reversing the process. In fact, heart attacks could even be increased in this older age group due to an increased risk for blood clots.

"The beneficial effects of HRT in younger postmenopausal women appear to be due to HRT’s ability to increase high-density lipoproteins ("good" fats) and reduce low-density lipoproteins ("bad" fats), glucose, weight, insulin levels, the incidence of new-onset diabetes and a handful of other risk factors for heart diseases," says Shelley Salpeter.

The Salpeters point out that the meta-analysis found no change in breast cancer deaths or total cancer deaths in women of all ages on HRT compared with those not on it, and it also showed a significant decrease in the risk of deaths from causes other than cancer or cardiovascular events, perhaps due to HRT’s other benefits. These other benefits include a 35 percent reduction in hip fracture and new-onset diabetes mellitus and a 60 percent reduction in recurrent urinary tract infections (which can lead to fatal sepsis). The authors conclude that each woman should make the decision regarding hormone replacement on an individual basis, taking into consideration her age, the degree of bothersome postmenopausal symptoms and her underlying health-risk factors.

The other co-authors of the study are Judith M.E. Walsh, M.D., of the University of California-San Francisco; and Elizabeth Greyber, M.D., and Thomas M. Ormiston, M.D., both of the Santa Clara Valley Medical Center. The study was funded, in part, by the Santa Clara Valley Medical Center and the University of California-San Francisco.

Susan S. Lang | EurekAlert!
Further information:
http://www.cornell.edu

More articles from Studies and Analyses:

nachricht Antarctic Ice Sheet mass loss has increased
14.06.2018 | Technische Universität Dresden

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>